Keyphrases
Liver Transplantation
100%
Liver Transplant Recipients
35%
Hepatocellular Carcinoma
17%
Transplantation
16%
Liver
15%
Tacrolimus
13%
AIDS/HIV
12%
Post-liver Transplantation
12%
Pediatric Liver Transplantation
12%
Hepatitis C Virus
11%
Immunosuppression
11%
Renal Disease
10%
Hepatitis C Virus Recurrence
10%
Patient Survival
10%
Hepatocellular Carcinoma Recurrence
9%
Hepatitis C
9%
Acute Liver Failure
9%
Ribavirin
8%
Liver Resection
8%
Adult Patients
8%
Co-infected Patients
8%
Everolimus
8%
Single-center Study
8%
Portal Vein Arterialization
8%
Pretransplant
8%
Cirrhosis
7%
Pediatric Patients
7%
Orthotopic Liver Transplantation
7%
Infected Patients
7%
Chronic Hepatitis C
6%
Pegylated Interferon
6%
Tumor
6%
Single Center
6%
Mycophenolate Mofetil
6%
Spain
6%
Retransplantation
6%
Adult Liver Transplantation
6%
Fibrolamellar
6%
Waiting List
5%
MTOR Inhibitor
5%
Sustained Virological Response
5%
Monotherapy
5%
Liver Biopsy
5%
Hebron
5%
Liver Allograft
5%
Donor-recipient Matching
5%
T Cells
5%
Hepatic Hilum
5%
Hepatocarcinoma
5%
Virus Hepatitis
5%
Medicine and Dentistry
Liver Transplantation
81%
Liver Graft
41%
Recurrent Disease
25%
Transplantation
20%
Hepatocellular Carcinoma
17%
Pediatrics
17%
Hepatitis C Virus
14%
Hepatic Portal Vein
13%
Immunosuppressive Treatment
11%
Liver Cirrhosis
11%
Hepatitis C
10%
Kidney Function
9%
Acute Liver Failure
8%
Immunity
8%
Hepatectomy
8%
Diseases
7%
Ribavirin
7%
Portal Vein Thrombosis
6%
Infection
6%
Allograft
6%
Neoplasm
6%
Pediatrics Patient
6%
Human Immunodeficiency Virus
5%
Peginterferon
5%
Liver Biopsy
5%
Fibrolamellar Hepatocellular Carcinoma
5%
Retransplantation
5%
Surgeon
5%
Cohort Analysis
5%
Liver Injury
5%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrent Disease
26%
Liver Cell Carcinoma
13%
Hepatitis C Virus
12%
Tacrolimus
12%
Liver Cirrhosis
12%
Hepatitis C
11%
Everolimus
8%
Side Effect
7%
Ribavirin
7%
Neoplasm
6%
Disease
6%
Prospective Study
6%
Mammalian Target of Rapamycin Inhibitor
5%
Peginterferon
5%
Mycophenolate Mofetil
5%
Cohort Study
5%
Monotherapy
5%
Reinfection
5%
